trials
-
Sports Medicine
Histogenics Announces Publication of MRI Data From NeoCart® Phase 1 and Phase 2 Clinical Trials in the American Journal of Sports Medicine
WALTHAM, Mass., Jan. 11, 2017 (GLOBE NEWSWIRE) — Histogenics Corporation (Histogenics) (HSGX), a regenerative medicine company focused on developing and…
Read More » -
HHS takes steps to provide more information about clinical trials to the public
Friday, September 16, 2016 In an effort to make information about clinical trials widely available to the public, the…
Read More » -
Hospitals
MiMedx Provides Update On Key Clinical Trials
MARIETTA, Ga., Aug. 30, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes…
Read More » -
Hospitals
Ampio announces results of Ampion™ trials
ENGLEWOOD, Colo., June 30, 2016 /PRNewswire/ — Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) announced today the results of the Ampion™ PIVOT clinical trial…
Read More » -
Biologics
SpinalCyte, LLC Announces Final Results From Phase II Animal Trials Using Human Dermal Fibroblast Transplantation for Intervertebral Disc Degeneration
HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on regrowth of the spinal disc nucleus using Human Dermal…
Read More » -
Recon
TissueGene, Inc. Presents Phase 2 Data for Its Novel Cell Therapy for the Treatment of Osteoarthritis of the Knee
ROCKVILLE, Md., May 11, 2015 /PRNewswire/ — TissueGene Inc. is pleased to announce that Dr. Moon Jong Noh, VP of Research…
Read More »